SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $681 | -37.2% | 24,688 | -31.6% | 0.03% | -36.5% |
Q2 2023 | $1,085 | -17.2% | 36,088 | -0.3% | 0.05% | -22.4% |
Q1 2023 | $1,311 | -8.6% | 36,188 | -10.0% | 0.07% | -14.1% |
Q4 2022 | $1,434 | -99.9% | 40,188 | 0.0% | 0.08% | +2.6% |
Q3 2022 | $1,360,000 | +17.0% | 40,188 | 0.0% | 0.08% | +24.6% |
Q2 2022 | $1,162,000 | -10.5% | 40,188 | 0.0% | 0.06% | +5.2% |
Q1 2022 | $1,299,000 | +10.8% | 40,188 | 0.0% | 0.06% | +9.4% |
Q4 2021 | $1,172,000 | -37.2% | 40,188 | -42.6% | 0.05% | -37.6% |
Q3 2021 | $1,867,000 | -16.1% | 69,988 | -3.2% | 0.08% | -14.1% |
Q2 2021 | $2,226,000 | +17.7% | 72,288 | 0.0% | 0.10% | +12.5% |
Q1 2021 | $1,892,000 | +4.0% | 72,288 | 0.0% | 0.09% | -2.2% |
Q4 2020 | $1,819,000 | +22.2% | 72,288 | +1.3% | 0.09% | -11.8% |
Q3 2020 | $1,488,000 | -12.0% | 71,388 | +0.3% | 0.10% | +5.2% |
Q2 2020 | $1,691,000 | +32.9% | 71,188 | +0.7% | 0.10% | +12.8% |
Q1 2020 | $1,272,000 | -24.2% | 70,688 | 0.0% | 0.09% | -5.5% |
Q4 2019 | $1,677,000 | -65.1% | 70,688 | -59.6% | 0.09% | -61.3% |
Q3 2019 | $4,806,000 | -12.0% | 174,888 | +5.9% | 0.24% | -10.6% |
Q2 2019 | $5,463,000 | -8.6% | 165,088 | -3.2% | 0.26% | -7.7% |
Q1 2019 | $5,977,000 | +5.2% | 170,588 | -0.3% | 0.28% | -5.0% |
Q4 2018 | $5,684,000 | -34.1% | 171,088 | -0.1% | 0.30% | -17.4% |
Q3 2018 | $8,619,000 | -15.9% | 171,188 | 0.0% | 0.36% | -23.7% |
Q2 2018 | $10,246,000 | +28.9% | 171,188 | -1.4% | 0.48% | +22.7% |
Q1 2018 | $7,948,000 | +13.6% | 173,535 | -1.1% | 0.39% | +20.5% |
Q4 2017 | $6,995,000 | -0.4% | 175,535 | -0.1% | 0.32% | -12.0% |
Q3 2017 | $7,025,000 | -7.2% | 175,635 | 0.0% | 0.37% | -10.9% |
Q2 2017 | $7,570,000 | +33.9% | 175,635 | -2.8% | 0.41% | +36.1% |
Q1 2017 | $5,654,000 | +17.4% | 180,635 | -5.2% | 0.30% | +15.3% |
Q4 2016 | $4,814,000 | +1.0% | 190,635 | -1.0% | 0.26% | -1.5% |
Q3 2016 | $4,764,000 | +21.4% | 192,635 | 0.0% | 0.27% | +14.7% |
Q2 2016 | $3,924,000 | – | 192,635 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |